In-vitro antibacterial activity of levofloxacin against hospital isolates: A multicentre study

Journal of Antimicrobial Chemotherapy

Volumn 43, Issue SUPPL. C, 1999, Pages 43-50

  Soussy, C J ^a   Cluzel, M ^b   Ploy, M C ^c   Kitzis, M D ^d   Morel, C ^e   Bryskier, A ^f   Courvalin, P ^g  

^a HENRI MONDOR HOSPITAL   (France)

^b UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^c LIMOGES UNIVERSITY HOSPITAL   (France)

^d SAINT JOSEPH HOSPITAL   (France)

^e CAEN UNIVERSITY HOSPITAL   (France)

^f Division Santé   (France)

^g INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOFLOXACIN; METICILLIN; NALIDIXIC ACID; OFLOXACIN; PEFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ACINETOBACTER BAUMANNII; AGAR GEL DIFFUSION; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; BACTEROIDES FRAGILIS; CLINICAL TRIAL; CLOSTRIDIUM PERFRINGENS; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HAEMOPHILUS INFLUENZAE; HAEMOPHILUS PARAINFLUENZAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA CATARRHALIS; MULTICENTER STUDY; NONHUMAN; REGRESSION ANALYSIS; RESPIRATORY TRACT INFECTION;

ACINETOBACTER; ANTI-INFECTIVE AGENTS; BACTERIA; DRUG RESISTANCE, MICROBIAL; ENTEROBACTERIACEAE; HOSPITALS, UNIVERSITY; HUMANS; MICROBIAL SENSITIVITY TESTS; OFLOXACIN; PSEUDOMONAS;

EID: 0032973337     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (18)

1. Jones, R. N. (1996). Impact of changing pathogens and antimicrobial susceptibility patterns in the treatment of serious infections in hospitalized patients. American Journal of Medicine 100, Suppl. 6A, 3-12S.
2. Goldstein, F. W. & Acar, J. F. (1996). Antimicrobial resistance among lower respiratory tract isolates of Streptococcus pneumoniae: results of 1992-93 western Europe and USA collaborative surveillance study. The Alexander Project Collaborative Group. Journal of Antimicrobial Chemotherapy 38, Suppl. A, 71-64.
3. Yamane, N., Jones, R. N., Frei, R., Hoban, D. J., Pignatari, A. C. & Marco, F. (1994). Levofloxacin in vitro activity: results from an international comparative study with ofloxacin and ciprofloxacin. Journal of Chemotherapy 6, 83-91.
4. Barry, A. L., Fuchs, P. C., Allen, S. D., Brown, S. D., Jorgensen, J. H. & Tenover, F. C. (1996). In vitro susceptibility of Streptococcus pneumoniae to the D-and L-isomers of ofloxacin: interpretive criteria and quality control limits. Journal of Antimicrobial Chemotherapy 37, 365-9.
5. Eliopoulos, G. M., Wennersten, C. B. & Moellering, R. C. (1996). Comparative in vitro activity of levofloxacin and ofloxacin against Gram-positive bacteria. Diagnostic Microbiology and Infectious Disease 25, 35-41.
6. Fish, D. N. & Chow, A. T. (1997). The clinical pharmacokinetics of levofloxacin. Clinical Pharmacokinetics 32, 101-19.
7. Swartz, M. N. (1997). Use of antimicrobial agents and drug resistance. New England Journal of Medicine 337, 491-2.
8. Comité de l'Antibiogramme de la Société Française de Microbiologie. (1996). Technical recommendations for in vitro susceptibility testing. Clinical Microbiology and Infection 2, Suppl. 1, 811-25.
9. Davis, R. & Bryson, H. M. (1994). Levofloxacin. A review of its antibacterial activity, pharmacokinetics and therapeutic efficacy. Drugs 47, 677-700.
10. Piddock, L. J. V. & Wise, R. (1988). The selection and frequency of streptococci with decreased susceptibility to ofloxacin compared with other quinolones. Journal of Antimicrobial Chemotherapy 22, Suppl. C, 45-51.
11. Lafredo, S. C., Foleno, B. D. & Fu, K. P. (1993). Induction of resistance of Streptococcus pneumoniae to quinolones in vitro. Chemotherapy 39, 36-9.
12. Thomson, K. S. & Sanders, C. C. (1994). Dissociated resistance among fluoroquinolones. Antimicrobial Agents and Chemotherapy 38, 2095-100.
13. Dholakia, N., Rolston, K. V. I., Ho, D. H., LeBlanc, B. & Bodey, G. P. (1994). Susceptibilities of bacterial isolates from patients with cancer to levofloxacin and other quinolones. Antimicrobial Agents and Chemotherapy 38, 848-52.
14. Cormican, M. G., Erwin, M. E., Marshall, S. A. & Jones, R. N. (1996). Susceptibility testing interpretive criteria for levofloxacin when testing respiratory pathogens, Haemophilus influenzae and Moraxella catarrhalis. Diagnostic Microbiology and Infectious Disease 24, 155-60.
15. George, J. & Morrissey, I. (1997). The bactericidal activity of levofloxacin compared with ofloxacin, D-ofloxacin, ciprofloxacin, sparfloxacin and cefotaxime against Streptococcus pneumoniae. Journal of Antimicrobial Chemotherapy 39, 719-23.
16. Fu, K. P., Lafredo, S. C., Foleno, B., Isaacson, D. M., Barrett, J. F., Tobia, A. J. et al. (1992). In vitro and in vivo antibacterial activities of levofloxacin (L-ofloxacin), an optically active ofloxacin. Antimicrobial Agents and Chemotherapy 36, 860-6.
17. Visalli, M. A., Jacobs, M. R. & Appelbaum, P. C. (1997). Susceptibility of twenty penicillin-susceptible and -resistant pneumococci to levofloxacin, ciprofloxacin, ofloxacin, erythromycin, azithromycin, and clarithromycin by MIC and time-kill. Diagnostic Microbiology and Infectious Disease 28, 131-7.
18. National Committee for Clinical Laboratory Standards. (1998). Performance Standards for Antimicrobial Susceptibility Testing - Eighth Informational Supplement M100-S8. NCCLS, Wayne, PA.